Kim Hyeong-Yeop, Bae Won-Young, Yu Hyung-Seok, Chang Kyung-Hoon, Hong Young-Ho, Lee Na-Kyoung, Paik Hyun-Dong
1Department of Food Science and Biotechnology of Animal Resources, Konkuk University, Seoul, 05029 Republic of Korea.
CJ CheilJedang Blossom Park, Suwon, Gyeonggi-do 16495 Republic of Korea.
Food Sci Biotechnol. 2019 Oct 15;29(4):569-578. doi: 10.1007/s10068-019-00690-w. eCollection 2020 Apr.
The objective of this study was to increase the bioavailability of (IB) through fermentation with probiotic D30, and to evaluate the chemical composition, viability, and anti-inflammatory effect of fermented (FIB). IB was fermented with D30 at 37 °C for 24 h. FIB increased total phenolic content and decreased total flavonoid content of IB. 1--acetylbritannilactone and ergolide production, which are associated with the viability, increased from 1.38 to 4.13 μg/mg, and decreased from 5.24 to 0.94 μg/mg, in the control and FIB, respectively. In addition, the cell viability of RAW264.7 cells increased when pretreated with 400 μg/mL FIB. FIB inhibited the production of nitric oxide and proinflammatory cytokines by inhibiting NF-κB and MAPKs pathways. Therefore, FIB with D30 reduced the toxicity and increased the anti-inflammatory properties. These results indicate that FIB is a potential beneficial bioactive agent for functional foods.
本研究的目的是通过与益生菌D30发酵来提高[物质名称未给出](IB)的生物利用度,并评估发酵后的[物质名称未给出](FIB)的化学成分、活力及抗炎效果。将IB与D30在37℃下发酵24小时。FIB增加了IB的总酚含量并降低了其总黄酮含量。与活力相关的1-乙酰基白檀内酯和麦角异羟肟酸的产量,在对照中从1.38μg/mg增加到4.13μg/mg,而在FIB中从5.24μg/mg降至0.94μg/mg。此外,用400μg/mL FIB预处理时,RAW264.7细胞的活力增加。FIB通过抑制NF-κB和MAPKs途径抑制一氧化氮和促炎细胞因子的产生。因此,与D30发酵得到的FIB降低了毒性并增强了抗炎特性。这些结果表明FIB是功能性食品中一种潜在的有益生物活性剂。